Dexcel Ltd. is a global pharmaceutical company that specializes in the development and manufacturing of high-quality generic and branded pharmaceutical products. With a focus on innovation and research, Dexcel is committed to improving healthcare outcomes for patients worldwide. The company operates state-of-the-art manufacturing facilities and adheres to strict quality standards to ensure the safety and efficacy of its products. Dexcel's extensive product portfolio covers various therapeutic areas, including cardiovascular, central nervous system, and gastrointestinal diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#4 in Or-Akiva

#797 in Israel

Or-Akiva, Israel

Dexcel Ltd.

Forward Citations = 36

8 inventors:

Yitshak Itsik Efrati (3 out of 3 patents)

Avi Avramoff (2 out of 15 patents)

Abraham Domb (2 out of 43 patents)

4. Valerie Azoulay (2 out of 3 patents)

5. Victor Pevzner (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dexcel Ltd.. Retrieved from https://idiyas.com/company/dexcel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]